Literature DB >> 12817091

Determinants of physical function in rheumatoid arthritis: association with the disease process.

J M W Hazes1.   

Abstract

Rheumatoid arthritis (RA) is a chronic, debilitating disease that follows a progressive course characterized by persistent inflammation and erosive joint damage leading to functional disability. The Health Assessment Questionnaire is now viewed as a key instrument to measure physical function, based on its reliability and ease of use. It has been demonstrated that multiple variables affect physical function, of which those most frequently indicated are disease activity, joint damage and the psychosocial characteristics of the patient. When these variables are pooled together the variation observed in a patient's physical function over the long term can be explained mainly by disease activity, partially by joint damage and additionally by psychosocial factors. Therefore, to maintain or improve physical function in long-standing RA, it is imperative to control disease activity and joint damage by early initiation of treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12817091     DOI: 10.1093/rheumatology/keg328

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  9 in total

Review 1.  Predictive factors of work disability in rheumatoid arthritis: a systematic literature review.

Authors:  E M de Croon; J K Sluiter; T F Nijssen; B A C Dijkmans; G J Lankhorst; M H W Frings-Dresen
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

2.  Sensory and vascular changes in a rat monoarthritis model: prophylactic and therapeutic effects of meloxicam.

Authors:  Javeria Ali Hashmi; Kiran Yashpal; David W Holdsworth; James L Henry
Journal:  Inflamm Res       Date:  2010-03-28       Impact factor: 4.575

3.  Osteoarthritis of the knee and hip: a comparison of factors associated with physical activity.

Authors:  Thomas Rosemann; Thomas Kuehlein; Gunter Laux; Joachim Szecsenyi
Journal:  Clin Rheumatol       Date:  2007-03-02       Impact factor: 2.980

Review 4.  Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts.

Authors:  Sam Norton; Bo Fu; David L Scott; Chris Deighton; Deborah P M Symmons; Allan J Wailoo; Jonathan Tosh; Mark Lunt; Rebecca Davies; Adam Young; Suzanne M M Verstappen
Journal:  Semin Arthritis Rheum       Date:  2014-05-09       Impact factor: 5.532

5.  Prevalence of depressive symptoms in patients with rheumatoid arthritis at a regional hospital in KwaZulu-Natal, South Africa.

Authors:  Mfundo Mabusela; Andrew Tomita; Saeeda Paruk; Farhanah Paruk
Journal:  S Afr J Psychiatr       Date:  2022-02-22       Impact factor: 1.550

6.  Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial.

Authors:  D van der Heijde; R Landewé; R van Vollenhoven; S Fatenejad; L Klareskog
Journal:  Ann Rheum Dis       Date:  2008-01-18       Impact factor: 19.103

Review 7.  The specialist physician's approach to rheumatoid arthritis in South Africa.

Authors:  Frederik C J Bester; Fredricka J Bosch; Barend J Jansen van Rensburg
Journal:  Korean J Intern Med       Date:  2016-02-26       Impact factor: 2.884

8.  Further Treatment Intensification in Undifferentiated and Rheumatoid Arthritis Patients Already in Low Disease Activity has Limited Benefit towards Physical Functioning.

Authors:  Sytske Anne Bergstra; Otto Olivas; Gülşah Akdemir; Naghmeh Riyazi; Gerard Collée; Johannes H L M van Groenendael; Robert B M Landewé; Cornelia F Allaart
Journal:  Arthritis Res Ther       Date:  2017-09-30       Impact factor: 5.156

9.  Comparative evaluation of efficacy, pharmacodynamics, and safety of Hetero's adalimumab (Mabura®, Hetero Biopharma Ltd.) and reference adalimumab (Humira®, Abbvie Inc.) in patients with active rheumatoid arthritis on concomitant methotrexate therapy.

Authors:  Shubhadeep Sinha; Biswadip Ghosh; Syamasis Bandyopadhyay; Firdaus Fatima; Vamsi Krishna Bandi; Pankaj Thakur; Bala Reddy; Sreenivasa Chary; Leela Talluri; Ajay Gupta; Amit Ramchandra Kale; Anil Kumar Gupta; Ashok Kumar P; Diwakar Reddy; Younus Mohammed; Soma Shekar; Sudheer T; Vijay G Goni; Vishnu Sharma; Vishwanath Yeligod
Journal:  BMC Rheumatol       Date:  2020-06-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.